BRD4
[1]. Hines J, et al. MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53. Cancer Res. 2019 Jan 1;79(1):251-262.
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!